Profile for Corbus Pharmaceuticals Holdings Inc. (CRBP)

$ 1.22 0.00 (0.00%) Volume: 3.1m 4:00 PM EST 24-Nov-2020
After Hours:  $ 1.20   -0.02 (-1.64%) Volume: 46.13k 7:58 PM EST 24-Nov-2020
Business Description:
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.
Address: 500 River Ridge Drive, Second Floor, Norwood, MA, US, 02062
Telephone: +1 617 963-0100 Website:
Facsimile: N/A Email: [email protected]
CEO: Yuval Cohen
Employees: 141 Market Cap: 102.53m
Issue Type: CS
Auditor: EisnerAmper LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1595097
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Pharmaceutical Preparations (2834)